Michael Luo CFA
Stock Analyst at CLSA
(4.05)
# 1,699
Out of 5,028 analysts
77
Total ratings
47.9%
Success rate
13.4%
Average return
Main Sectors:
Stocks Rated by Michael Luo CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Initiated Coverage: Buy | $748 | $654.80 | +14.23% | 1 | Sep 3, 2026 | |
| CRL Charles River Laboratories International | Downgraded: Hold | $219 | $290.19 | -24.53% | 5 | Jul 20, 2026 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Reiterated: Buy | $58.90 → $52.10 | $45.56 | +14.35% | 8 | Oct 30, 2025 | |
| HKG: 2359 WuXi AppTec Co., Ltd. | Reiterated: Buy | $137.10 → $138.60 | $211.20 | -34.38% | 13 | Oct 27, 2025 | |
| HKG: 6078 Hygeia Healthcare Holdings Co., Limited | Reiterated: Buy | $17.30 → $17.00 | $9.38 | n/a | 6 | Aug 29, 2025 | |
| HKG: 1951 Jinxin Fertility Group Limited | Reiterated: Buy | $3.80 → $3.50 | $2.11 | n/a | 3 | Aug 28, 2025 | |
| HKG: 6821 Asymchem Laboratories (Tianjin) Co., Ltd. | Reiterated: Buy | $74.30 → $110.20 | $163.30 | n/a | 7 | Aug 27, 2025 | |
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Reiterated: Buy | $34.80 → $42.60 | $55.10 | n/a | 9 | Aug 25, 2025 | |
| HKG: 0867 China Medical System Holdings Limited | Reiterated: Buy | $10.00 → $15.60 | $10.51 | n/a | 4 | Aug 20, 2025 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Reiterated: Buy | $27.80 → $43.10 | $34.02 | n/a | 2 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.00 → $9.20 | $5.54 | n/a | 3 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥3,230 | ¥2,286 | n/a | 1 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥2,490 | ¥3,354 | n/a | 1 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63.00 → $42.00 | $25.86 | n/a | 2 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 702.00 → CHF 723.00 | CHF 565.60 | n/a | 7 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥2,850 | ¥1,947 | n/a | 1 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $9.80 → $11.00 | $30.34 | n/a | 3 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1.50 | $1.18 | n/a | 1 | Apr 4, 2024 |
Thermo Fisher Scientific
Sep 3, 2026
Initiated Coverage: Buy
Price Target: $748
Current: $654.80
Upside: +14.23%
Charles River Laboratories International
Jul 20, 2026
Downgraded: Hold
Price Target: $219
Current: $290.19
Upside: -24.53%
Hangzhou Tigermed Consulting Co., Ltd
Oct 30, 2025
Reiterated: Buy
Price Target: $58.90 → $52.10
Current: $45.56
Upside: +14.35%
WuXi AppTec Co., Ltd.
Oct 27, 2025
Reiterated: Buy
Price Target: $137.10 → $138.60
Current: $211.20
Upside: -34.38%
Hygeia Healthcare Holdings Co., Limited
Aug 29, 2025
Reiterated: Buy
Price Target: $17.30 → $17.00
Current: $9.38
Upside: n/a
Jinxin Fertility Group Limited
Aug 28, 2025
Reiterated: Buy
Price Target: $3.80 → $3.50
Current: $2.11
Upside: n/a
Asymchem Laboratories (Tianjin) Co., Ltd.
Aug 27, 2025
Reiterated: Buy
Price Target: $74.30 → $110.20
Current: $163.30
Upside: n/a
WuXi Biologics (Cayman) Inc.
Aug 25, 2025
Reiterated: Buy
Price Target: $34.80 → $42.60
Current: $55.10
Upside: n/a
China Medical System Holdings Limited
Aug 20, 2025
Reiterated: Buy
Price Target: $10.00 → $15.60
Current: $10.51
Upside: n/a
Hansoh Pharmaceutical Group Company Limited
Aug 20, 2025
Reiterated: Buy
Price Target: $27.80 → $43.10
Current: $34.02
Upside: n/a
Jul 21, 2025
Reiterated: Buy
Price Target: $7.00 → $9.20
Current: $5.54
Upside: n/a
May 20, 2025
Reiterated: Buy
Price Target: ¥3,230
Current: ¥2,286
Upside: n/a
May 20, 2025
Reiterated: Buy
Price Target: ¥2,490
Current: ¥3,354
Upside: n/a
Apr 8, 2025
Reiterated: Buy
Price Target: $63.00 → $42.00
Current: $25.86
Upside: n/a
Dec 12, 2024
Reiterated: Buy
Price Target: CHF 702.00 → CHF 723.00
Current: CHF 565.60
Upside: n/a
Nov 13, 2024
Reiterated: Buy
Price Target: ¥2,850
Current: ¥1,947
Upside: n/a
Apr 10, 2024
Upgraded: Buy
Price Target: $9.80 → $11.00
Current: $30.34
Upside: n/a
Apr 4, 2024
Reiterated: Sell
Price Target: $1.50
Current: $1.18
Upside: n/a